Progression of genomic signatures in local and metastatic estrogen receptor-positive (ER plus ) breast cancer: Relevance to palliative treatment

被引：0
|
作者：
Symmans, William Fraser
Andreopoulou, Eleni
Booser, Daniel J.
Hatzis, Christos
Wallace, Michael J.
Zhang, Ya
Gong, Yun
Ignatiadis, Michail
Sotiriou, Christos
Andre, Fabrice
Peintinger, Florentina
Regitnig, Peter
Marth, Christian
Desmedt, Christine
Loi, Sherene
Moulder, Stacy L.
Hortobagyi, Gabriel N.
Pusztai, Lajos
Valero, Vicente
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Nuvera Biosci Inc, Woburn, MA USA
[3] Inst Jules Bordet, B-1000 Brussels, Belgium
[4] Inst Gustave Roussy, Villejuif, France
[5] Graz Univ, Graz, Austria
[6] Med Univ Innsbruck, A-6020 Innsbruck, Austria
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
515
引用
收藏
页数：1
相关论文
共 50 条
  • [31] New Strategies in Estrogen Receptor-Positive Breast Cancer
    Johnston, Stephen R. D.
    CLINICAL CANCER RESEARCH, 2010, 16 (07) : 1979 - 1987
  • [32] Geographic excess of estrogen receptor-positive breast cancer
    Benz, CC
    Clarke, CA
    Moore, DH
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2003, 12 (12) : 1523 - 1527
  • [33] Estrogen receptor-positive breast cancer: a multidisciplinary challenge
    Zwart, Wilbert
    Theodorou, Vasiliki
    Carroll, Jason S.
    WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE, 2011, 3 (02) : 216 - 230
  • [34] Risk factors for estrogen receptor-positive breast cancer
    Hwang, ES
    Chew, T
    Shiboski, S
    Farren, G
    Benz, CC
    Wrensch, M
    ARCHIVES OF SURGERY, 2005, 140 (01) : 58 - 62
  • [35] Metastasis Dormancy in Estrogen Receptor-Positive Breast Cancer
    Zhang, Xiang H. -F.
    Giuliano, Mario
    Trivedi, Meghana V.
    Schiff, Rachel
    Osborne, C. Kent
    CLINICAL CANCER RESEARCH, 2013, 19 (23) : 6389 - 6397
  • [36] Latest generation estrogen receptor degraders for the treatment of hormone receptor-positive breast cancer
    Chen, Ya-Chi
    Yu, Jiajie
    Metcalfe, Ciara
    De Bruyn, Tom
    Gelzleichter, Thomas
    Malhi, Vikram
    Perez-Moreno, Pablo D.
    Wang, Xiaojing
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2022, 31 (06) : 515 - 529
  • [37] RACIAL/ETHNIC DIFFERENCES IN USE OF ADJUVANT HORMONAL THERAPY AMONG WOMEN WITH ESTROGEN RECEPTOR-POSITIVE (ER plus ) BREAST CANCER
    Livaudais, J.
    Li, C.
    John, E.
    Daly, M.
    Terry, M.
    Buys, S.
    Thompson, B.
    LaCroix, A.
    Habel, L.
    Coronado, G.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2010, 171 : S23 - S23
  • [38] The Experience of Initiating Oral Adjuvant Treatment for Estrogen Receptor-Positive Breast Cancer
    Flanagan, Jane
    Tetler, Devin
    Winters, Loren
    Post, Kathryn
    Habin, Karleen
    ONCOLOGY NURSING FORUM, 2016, 43 (04) : E143 - E152
  • [39] Cardiometabolic Effects of Endocrine Treatment of Estrogen Receptor-Positive Early Breast Cancer
    Cheung, Yee-Ming
    Ramchand, Sabashini K.
    Yeo, Belinda
    Grossmann, Mathis
    JOURNAL OF THE ENDOCRINE SOCIETY, 2019, 3 (07) : 1283 - 1301
  • [40] Polyendocrine Treatment in Estrogen Receptor-Positive Breast Cancer: A "FACT" Yet to Be Proven
    Di Leo, Angelo
    Malorni, Luca
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (16) : 1897 - 1900
12345